Christian Joyner
Physician Assistant · Norfolk, VANPI 1649495888
Payments from drug & device makers
Across 151 payments — averaging $22.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$713
- Lilly USA, LLC$499
- Amgen$247
- Otsuka America Pharmaceutical, Inc.$150
- Novo Nordisk$95
- plus $567 from 15 others
What the payments were for
- Food & beverage$3,450100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 33 | $1,189 |
| AbbVie | 42 | $713 |
| Lilly USA, LLC | 24 | $499 |
| Amgen | 9 | $247 |
| Otsuka America Pharmaceutical, Inc. | 7 | $150 |
| Novo Nordisk | 5 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| Lundbeck LLC | 3 | $67 |
| Phadia US Inc. | 4 | $66 |
| GSK | 3 | $53 |
| Pfizer | 3 | $52 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Boehringer Ingelheim | 2 | $41 |
| Scynexis, Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Bayer | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
| Merck | 1 | $17 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
| Exact Sciences | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,458 in reported general payments places this provider in the 90th percentile of 3,376 physician assistant providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 35 | $57,580 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $17,013 |
| XareltoRivaroxaban | 17 | $13,703 |
| Carbamazepine ErCarbamazepine | 15 | $2,116 |
| Liothyronine Sodium | 14 | $628 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $560 |
| Omeprazole | 32 | $535 |
| Rosuvastatin Calcium | 21 | $469 |
| Duloxetine Hcl | 13 | $354 |
| Atorvastatin Calcium | 32 | $349 |
| Celecoxib | 11 | $342 |
| Montelukast Sodium | 24 | $273 |
| Levothyroxine Sodium | 28 | $267 |
| Losartan Potassium | 26 | $264 |
| ClopidogrelClopidogrel Bisulfate | 15 | $231 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $499 | $57,58035 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Norfolk
- Melissa AlcoxNorfolk$73K
- Hillary HartungNorfolk$62K
- Stephanie HadleyNorfolk$15K
- Danielle JohnsonNorfolk$13K
- Ericka ThompsonNorfolk$13K
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Lindsay TomReston$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.